Kalbe targets year-end income at IDR1.59 trillion

JAKARTA: PT Kalbe Farma Tbk targets to gain IDR1.59 trillion-IDR1.61 trillion income until the end of next year. It will be 12%-15% higher than this years estimated earnings.Corporate Secretary of Kalbe Farma Vidjongtius said until the end of this year
News Editor | 16 Desember 2010 06:55 WIB

JAKARTA: PT Kalbe Farma Tbk targets to gain IDR1.59 trillion-IDR1.61 trillion income until the end of next year. It will be 12%-15% higher than this years estimated earnings.Corporate Secretary of Kalbe Farma Vidjongtius said until the end of this year the pharmaceutical company expects to grab IDR1.3 trillion-IDR1.4 trillion income. Whereas, until the third quarter of 2010, the income has arrived at IDR901.93 billion.The income gain is line with the higher revenue forecast until the end of 2010, which could reach IDR10 trillion. The revenue was IDR7.27 trillion until the third quarter of 2010.By next year, we plan to launch 10-15 new products, including an isotonic drink. We expect they can enhance our revenue. Until the end of 2010, the revenue is predicted to stand at IDR10 trillion, he explained.Previously, Vidjongtius confirmed that the company starts developing the isotonic drink whose annual growth is estimated at 15% or more compared to the energy drink. (T01/NOM)

Pantau terus perkembangan Real Count KPU Pilpres 2019, di sini.

Simak berita lainnya seputar topik artikel ini, di sini :

Editor : Muhammad Fariz Aulia

Berita Terkait



Berita Terkini Lainnya



Top
Tutup